期刊文献+

雌黄纳米粒的制备与表征 被引量:5

Preparation and evaluation of orpiment nanoparticles
在线阅读 下载PDF
导出
摘要 研究了含砷类中药新剂型—雌黄纳米粒的制备方法,为深入探讨雌黄抗癌的尺寸效应、作用机理和新的制剂工艺奠定基础。采用化学法制备雌黄纳米粒:(1)以砒霜、硫代乙酰胺(TAA)和盐酸为原料,分别用不同溶剂、控制反应物浓度和反应体系pH值、加入表面活性剂对比研究制备雌黄纳米粒;(2)用透射电镜(TEM)、X射线能谱(EDS)对雌黄纳米粒进行分析表征。实验制备了五种不同粒径的雌黄纳米粒,电镜下呈圆形或椭圆形,分散性较好,平均直径大小约为20nm、60nm、80nm1、40nm和400nm。 New methods of preparing orpiment ( As2S3 ) nanoparticles, a new form of Chinese medicine containing arsenic, were developed and their size effects against cancer were investigated. Orpiment nanoparticles were prepared by using arsenic trioxide and thioacetamide, H2O and CH3 CH2OH as solvent and adding some surfactant, controlling reactant consistency and reacting system pH value, and characterized by TEM and EDS . Five kinds of orpiment nanoparticles with average diameter of about 20nm, 60nm, 80nm, 140nm and 400nm were prepared and examined by TEM in our study. EDS identified the prepared nanoparticles were As2S3 and without other components.
出处 《电子显微学报》 CAS CSCD 2005年第6期604-607,共4页 Journal of Chinese Electron Microscopy Society
基金 国家自然科学基金资助项目(No.30371830) 国家高技术研究发展计划(863计划)资助项目(No.2002AA302207) 江苏省自然科学基金资助项目(No.BK2001003) 江苏省中医药中西医结合重点资助项目(No.H027) 东南大学科学基金资助项目(No.9223001162).~~
关键词 雌黄 纳米粒 orpiment nanoparticles
  • 相关文献

参考文献11

二级参考文献45

  • 1王振义,孙关林,陈竺.诱导分化疗法应用的现状[J].中华血液学杂志,1994,15(2):105-107. 被引量:28
  • 2黄世林,郭爱霞,向阳,王晓波,林慧娴,富丽.复方青黛片为主治疗急性早幼粒细胞白血病的临床研究[J].中华血液学杂志,1995,16(1):26-28. 被引量:185
  • 3张鹏,王树叶,胡龙虎,施福东,邱凤琴,洪珞珈,韩雪英,杨惠芬,宋颖昭,刘艳平,周晋,金镇敬.三氧化二砷注射液治疗72例急性早幼粒细胞白血病[J].中华血液学杂志,1996,17(2):58-60. 被引量:476
  • 4郑根建,周嘉秀,李德伦,周岚.平阳霉素磁控缓释微球的制备[J].华西口腔医学杂志,1996,14(3):220-222. 被引量:7
  • 5[2]Kenneth M, Baldwin J. Research in exercise sciences: Where do we go from here[J]? J Appl Physiol, 2000, 88: 332-336
  • 6[3]Afshari CA, Nuwaysir EF, Barrett JC. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safty evalution[J]. Cancer Res, 1999, 59(19): 4759-4760
  • 7[1]Lu DP, Qiu JY, Jiang B, et al. Effective treatment of acute promyelocytic leukemia (APL) with tetra-arsenic tetra-sulfide (As4S4), A monoinstitutional study (abstract)[J]. Blood, 1999,94(10, Suppl 1): 698a
  • 8[4]Saleh A, Srinivasa MS, Samir A, et al. Cytochrome C and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation[J]. J Biol Chem, 1999, 274(25): 17941-17945
  • 9[6]Makoto I, Akihisa N, Shigeki J, et al. Wee1-like gene in human cells[J]. Nature, 1991, 353(6339): 80-83
  • 10MUHLEN A Z, MEHNERT W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles[J].Pharmazie, 1998,53 (8): 552-559.

共引文献115

同被引文献41

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部